CN104098572A - 替卡格雷共晶型 - Google Patents
替卡格雷共晶型 Download PDFInfo
- Publication number
- CN104098572A CN104098572A CN201310119094.XA CN201310119094A CN104098572A CN 104098572 A CN104098572 A CN 104098572A CN 201310119094 A CN201310119094 A CN 201310119094A CN 104098572 A CN104098572 A CN 104098572A
- Authority
- CN
- China
- Prior art keywords
- adz6140
- ray powder
- powder diffraction
- diffraction pattern
- cocrystallizing type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
编号 | 2θ[°] | d-间距[Å] | 相对强度 [%] |
1 | 6.08 | 14.54 | 100 |
2 | 8.48 | 10.42 | 11.58 |
3 | 11.26 | 7.86 | 22.21 |
4 | 13.62 | 6.50 | 16.41 |
5 | 17.06 | 5.20 | 47.94 |
6 | 18.19 | 4.88 | 17.31 |
7 | 18.84 | 4.71 | 20.00 |
8 | 21.03 | 4.23 | 12.87 |
9 | 23.77 | 3.74 | 10.62 |
编号 | 2θ[°] | d-间距[Å] | 相对强度 [%] |
1 | 3.15 | 28.05 | 100.00 |
2 | 8.54 | 10.35 | 95.42 |
3 | 9.81 | 9.02 | 33.29 |
4 | 12.44 | 7.12 | 58.97 |
5 | 18.30 | 4.85 | 43.22 |
6 | 19.03 | 4.66 | 77.02 |
7 | 19.55 | 4.54 | 30.19 |
8 | 24.24 | 3.67 | 33.67 |
9 | 26.11 | 3.41 | 44.29 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310119094.XA CN104098572A (zh) | 2013-04-08 | 2013-04-08 | 替卡格雷共晶型 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310119094.XA CN104098572A (zh) | 2013-04-08 | 2013-04-08 | 替卡格雷共晶型 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104098572A true CN104098572A (zh) | 2014-10-15 |
Family
ID=51667155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310119094.XA Pending CN104098572A (zh) | 2013-04-08 | 2013-04-08 | 替卡格雷共晶型 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104098572A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1432018A (zh) * | 2000-06-02 | 2003-07-23 | 阿斯特拉曾尼卡有限公司 | ***并[4,5-d]嘧啶化合物的新晶形和非晶形 |
CN101443328A (zh) * | 2006-04-05 | 2009-05-27 | 安斯泰来制药有限公司 | C-糖苷衍生物和l-脯氨酸的共结晶体 |
CN102167715A (zh) * | 2011-03-07 | 2011-08-31 | 上海惠斯生物科技有限公司 | 一种钠-葡萄糖协同运转蛋白-2原料药的共晶制备方法 |
WO2012164286A1 (en) * | 2011-06-01 | 2012-12-06 | Astrazeneca Ab | Novel ticagrelor co - crystal |
CN102813664A (zh) * | 2011-06-12 | 2012-12-12 | 王定豪 | 包含格雷类药物和阿司匹林的口服肠溶制剂 |
-
2013
- 2013-04-08 CN CN201310119094.XA patent/CN104098572A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1432018A (zh) * | 2000-06-02 | 2003-07-23 | 阿斯特拉曾尼卡有限公司 | ***并[4,5-d]嘧啶化合物的新晶形和非晶形 |
CN101443328A (zh) * | 2006-04-05 | 2009-05-27 | 安斯泰来制药有限公司 | C-糖苷衍生物和l-脯氨酸的共结晶体 |
CN102167715A (zh) * | 2011-03-07 | 2011-08-31 | 上海惠斯生物科技有限公司 | 一种钠-葡萄糖协同运转蛋白-2原料药的共晶制备方法 |
WO2012164286A1 (en) * | 2011-06-01 | 2012-12-06 | Astrazeneca Ab | Novel ticagrelor co - crystal |
CN102813664A (zh) * | 2011-06-12 | 2012-12-12 | 王定豪 | 包含格雷类药物和阿司匹林的口服肠溶制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI786110B (zh) | (s)-2-乙基丁基2-(((s)-(((2r,3s,4r,5r) -5-(4-胺基吡咯并[2,1-f][1,2,4]三嗪-7-基)-5-氰基-3,4-二羥基四氫呋喃-2-基)甲氧基)(苯氧基)磷醯基)胺基)丙酸酯之結晶形式 | |
CN105753789A (zh) | 奥拉帕尼与尿素的共晶及其制备方法 | |
CN105164105B (zh) | 吡咯衍生物的结晶及其制备方法 | |
CN103965114A (zh) | 氘代的苯基氨基嘧啶化合物以及包含该化合物的药物组合物 | |
CN105237452A (zh) | 一种度骨化醇的新结晶形式及其制备方法 | |
CN104892628B (zh) | 银杏内酯k衍生物及其制备方法和用途 | |
CN113072588A (zh) | 一类含有青蒿琥酯的四价铂配合物及其制备方法与应用 | |
CN106008468A (zh) | 玻玛西尼a晶型、b晶型、c晶型及其制备方法 | |
CN103724374B (zh) | 一种苯磷硫胺化合物及制备方法及其含有该化合物的药物组合物 | |
CN111808117B (zh) | 青蒿素-苯胺基喹唑啉类d类衍生物及其药物组合物和应用 | |
CN108341805A (zh) | 可用作c-fms激酶抑制剂的取代的吡啶衍生物 | |
CN104098572A (zh) | 替卡格雷共晶型 | |
CN105418487B (zh) | 咔唑磺酰胺衍生物共晶及其制备方法 | |
CN104098571A (zh) | 替卡格雷的晶型及其制备方法 | |
CN102351812B (zh) | 甲磺酸桂哌齐特晶型iii及其制备方法 | |
CN103772393A (zh) | 替卡格雷的晶型及其制备方法 | |
CN109111419A (zh) | 7,8-含取代基香豆素衍生物及其制备方法和用途 | |
Chen et al. | Design, synthesis and biological evaluation of novel alkyl diamine linked bivalent β-carbolines as angiogenesis inhibitors | |
CN102351835B (zh) | 芒果苷元晶型及其组合物、制备方法与应用 | |
CN108017608A (zh) | 一类黄酮衍生物及其制备方法和用途 | |
CN105998018A (zh) | 吡非尼酮衍生物在制药中的应用 | |
CN102786458B (zh) | 吡咯甲酰胺衍生物、其制备方法和用途 | |
CN105175326B (zh) | 5‑甲基‑2(1h)吡啶酮衍生物及其制备方法和用途 | |
CN112094312B (zh) | 环维黄杨星d二盐酸盐的晶型a | |
CN103058951A (zh) | 一种新型非布索坦药物共晶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Suzhou City, Jiangsu Province, Suzhou Industrial Park 215123 Xinghu Street No. 218 Nano Technology Park building C25 Applicant after: Borui Pharmaceutical (Suzhou) Limited by Share Ltd Applicant after: Crystal Pharmatech Co., Ltd. Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 BioBAY building C27 Applicant before: Borui Bio-medical Technology (Jiangsu) Co., Ltd. Applicant before: Crystal Pharmatech Co., Ltd. |
|
COR | Change of bibliographic data | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141015 |
|
RJ01 | Rejection of invention patent application after publication |